Based in Florida and New York, BioCatalyst International partners
with early stage life science companies to prepare and implement a
successful product launch into the US drug discovery market.
BioCatalyst helps the transition to an aggressive growth strategy
that will contribute significant long term value to the business.
BioCatalyst can assist European startups to pursue a direct global
customer reach without the need to establish a full time subsidiary.
Our founding principal, Sheridan Snyder, is among the most
recognized names in the life science industry and has built some of
the world’s leading biotechnology companies, including Genzyme,
Biotage/Dyax, and Upstate Cell Signaling Solutions.